FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366422414> ?p ?o ?g. }

• W4366422414 abstract "Abstract Background The incidence of non-alcoholic fatty liver disease (NAFLD) has been on the rise in recent years, and there are no effective drugs to treat NAFLD; therefore, effective prevention and treatment of NAFLD have become a new challenge. Danggui Shaoyao Powder (DGSY) is a classic prescription commonly used in clinical practice and has been shown to reduce hepatic steatosis in patients with NAFLD. In addition, previous studies have shown that DGSY can alleviate hepatic steatosis and inflammation in NAFLD mice. Although clinical practice and basic studies have shown that DGSY is effective in NAFLD, high levels of clinical evidence are lacking. Therefore, a standardized RCT study protocol is required to evaluate its clinical efficacy and safety. Methods and analysis This study will be a randomized, double-blind, placebo-controlled, and single-center trial. According to the random number table, NAFLD participants will be randomly divided into the DGSY or placebo group for 24 weeks. The follow-up period will be 6 weeks after drug withdrawal. The primary outcome is the relative change in MRI-proton density fat fraction (MRI-PDFF) from baseline to 24 weeks. Absolute changes in serum alanine aminotransferase (ALT), liver stiffness measurement (LSM), body mass index (BMI), blood lipid, blood glucose, and insulin resistance index will be selected as secondary outcomes to comprehensively evaluate the clinical efficacy of DGSY in the treatment of NAFLD. The safety of DGSY will be evaluated by renal function, routine blood and urine tests, and electrocardiogram. Discussion This study will provide evidence-based medical corroboration for the clinical application of DGSY and promote the development and application of this classic prescription. Trial registration http://www.chictr.org.cn . Trial number: ChiCTR2000029144. Registered on 15 Jan 2020." @default.
• W4366422414 created "2023-04-21" @default.
• W4366422414 creator A5005988892 @default.
• W4366422414 creator A5021695326 @default.
• W4366422414 creator A5039625704 @default.
• W4366422414 creator A5042157361 @default.
• W4366422414 creator A5043234647 @default.
• W4366422414 creator A5046937939 @default.
• W4366422414 creator A5047124158 @default.
• W4366422414 creator A5050469170 @default.
• W4366422414 creator A5060873195 @default.
• W4366422414 creator A5061017141 @default.
• W4366422414 creator A5062608793 @default.
• W4366422414 creator A5069129079 @default.
• W4366422414 creator A5071595650 @default.
• W4366422414 creator A5077153113 @default.
• W4366422414 date "2023-04-19" @default.
• W4366422414 modified "2023-10-09" @default.
• W4366422414 title "Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial" @default.
• W4366422414 cites W2162382402 @default.
• W4366422414 cites W2171811563 @default.
• W4366422414 cites W2357781487 @default.
• W4366422414 cites W2462595066 @default.
• W4366422414 cites W2734724639 @default.
• W4366422414 cites W2770129291 @default.
• W4366422414 cites W2791708447 @default.
• W4366422414 cites W2900934742 @default.
• W4366422414 cites W2944625943 @default.
• W4366422414 cites W2955630694 @default.
• W4366422414 cites W2985579744 @default.
• W4366422414 cites W2993083975 @default.
• W4366422414 cites W3001786135 @default.
• W4366422414 cites W3003865038 @default.
• W4366422414 cites W3082261340 @default.
• W4366422414 cites W3154897461 @default.
• W4366422414 cites W3178219128 @default.
• W4366422414 cites W4293544956 @default.
• W4366422414 doi "https://doi.org/10.1186/s12906-023-03948-3" @default.
• W4366422414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37076843" @default.
• W4366422414 hasPublicationYear "2023" @default.
• W4366422414 type Work @default.
• W4366422414 citedByCount "1" @default.
• W4366422414 crossrefType "journal-article" @default.
• W4366422414 hasAuthorship W4366422414A5005988892 @default.
• W4366422414 hasAuthorship W4366422414A5021695326 @default.
• W4366422414 hasAuthorship W4366422414A5039625704 @default.
• W4366422414 hasAuthorship W4366422414A5042157361 @default.
• W4366422414 hasAuthorship W4366422414A5043234647 @default.
• W4366422414 hasAuthorship W4366422414A5046937939 @default.
• W4366422414 hasAuthorship W4366422414A5047124158 @default.
• W4366422414 hasAuthorship W4366422414A5050469170 @default.
• W4366422414 hasAuthorship W4366422414A5060873195 @default.
• W4366422414 hasAuthorship W4366422414A5061017141 @default.
• W4366422414 hasAuthorship W4366422414A5062608793 @default.
• W4366422414 hasAuthorship W4366422414A5069129079 @default.
• W4366422414 hasAuthorship W4366422414A5071595650 @default.
• W4366422414 hasAuthorship W4366422414A5077153113 @default.
• W4366422414 hasBestOaLocation W43664224141 @default.
• W4366422414 hasConcept C126322002 @default.
• W4366422414 hasConcept C141071460 @default.
• W4366422414 hasConcept C142724271 @default.
• W4366422414 hasConcept C168563851 @default.
• W4366422414 hasConcept C204787440 @default.
• W4366422414 hasConcept C27081682 @default.
• W4366422414 hasConcept C2776175330 @default.
• W4366422414 hasConcept C2778772119 @default.
• W4366422414 hasConcept C2779134260 @default.
• W4366422414 hasConcept C2780221984 @default.
• W4366422414 hasConcept C2992208098 @default.
• W4366422414 hasConcept C512861765 @default.
• W4366422414 hasConcept C535046627 @default.
• W4366422414 hasConcept C71924100 @default.
• W4366422414 hasConcept C90924648 @default.
• W4366422414 hasConceptScore W4366422414C126322002 @default.
• W4366422414 hasConceptScore W4366422414C141071460 @default.
• W4366422414 hasConceptScore W4366422414C142724271 @default.
• W4366422414 hasConceptScore W4366422414C168563851 @default.
• W4366422414 hasConceptScore W4366422414C204787440 @default.
• W4366422414 hasConceptScore W4366422414C27081682 @default.
• W4366422414 hasConceptScore W4366422414C2776175330 @default.
• W4366422414 hasConceptScore W4366422414C2778772119 @default.
• W4366422414 hasConceptScore W4366422414C2779134260 @default.
• W4366422414 hasConceptScore W4366422414C2780221984 @default.
• W4366422414 hasConceptScore W4366422414C2992208098 @default.
• W4366422414 hasConceptScore W4366422414C512861765 @default.
• W4366422414 hasConceptScore W4366422414C535046627 @default.
• W4366422414 hasConceptScore W4366422414C71924100 @default.
• W4366422414 hasConceptScore W4366422414C90924648 @default.
• W4366422414 hasIssue "1" @default.
• W4366422414 hasLocation W43664224141 @default.
• W4366422414 hasLocation W43664224142 @default.
• W4366422414 hasLocation W43664224143 @default.
• W4366422414 hasOpenAccess W4366422414 @default.
• W4366422414 hasPrimaryLocation W43664224141 @default.
• W4366422414 hasRelatedWork W1964078018 @default.
• W4366422414 hasRelatedWork W2103809310 @default.
• W4366422414 hasRelatedWork W2116375475 @default.
• W4366422414 hasRelatedWork W2379428236 @default.
• W4366422414 hasRelatedWork W2393331441 @default.
• W4366422414 hasRelatedWork W2913408213 @default.

• next